22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › SKYE BIOSCIENCE INC. › 2024-2025

SKYE BIOSCIENCE INC. 2024-2025 Proxy Voting Records

At SKYE BIOSCIENCE INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held October 22, 2024 and June 6, 2025), 92 asset managers reported how they voted in their SEC Form N-PX filings, covering 827 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held June 6, 2025 — Consider and vote upon, on an advisory basis, the compensation of our named executive officers… — SKYE BIOSCIENCE INC.'s filing reports the proposal as approved, with 86% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: SKYE BIOSCIENCE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2025.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and SKYE BIOSCIENCE INC.’s Form 8-K, filed June 11, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.

  • 10Reported items
  • 92Asset managers
  • 827Fund votes
  • June 6, 2025Main meeting date

Results at a glance

Meeting of June 6, 2025: 8 items on SKYE BIOSCIENCE INC.’s Form 8-K, filed June 11, 2025: 6 elected · 2 approved.

Meeting of October 22, 2024: 1 item on SKYE BIOSCIENCE INC.’s Form 8-K, filed October 24, 2024: 1 without a stated outcome.

Material dissent

  • The following are the voting results of the proposal to approve the Amended and Restated Plan that was presented to the Company's… 74% of votes cast Outcome not stated Under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025

Explore SKYE BIOSCIENCE INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by SKYE BIOSCIENCE INC.

These tallies are SKYE BIOSCIENCE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. SKYE BIOSCIENCE INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.

SKYE BIOSCIENCE INC. — official shareholder meeting results, meeting held June 6, 2025 (Form 8-K, filed June 11, 2025)
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Paul Grayson 16,982,420---- 2,881,7745,608,698 85%Elected—
Elect Director: Deborah Charych 18,867,541---- 996,6535,608,698 95%Elected—
Elect Director: Punit Dhillon 18,059,129---- 1,805,0655,608,698 91%Elected—
Elect Director: Annalisa Jenkins 19,597,696---- 266,4985,608,698 99%Elected—
Elect Director: Karen Smith 18,048,013---- 1,816,1815,608,698 91%Elected—
Elect Director: Andrew J. Schwab 17,746,927---- 2,117,2675,608,698 89%Elected—
2. The ratification of the selection of Marcum as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 25,418,81417,40236,676 ---- 99.9%Approved—
3. The approval, on an advisory basis, of the compensation of the Company's named executive officers, as disclosed in the Proxy Statement 17,064,0842,736,11663,994 --5,608,698 86%Approved—

Source: SKYE BIOSCIENCE INC., Form 8-K, filed with the SEC on June 11, 2025 — read the filing on EDGAR.

SKYE BIOSCIENCE INC. — official shareholder meeting results, meeting held October 22, 2024 (Form 8-K, filed October 24, 2024)
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
The following are the voting results of the proposal to approve the Amended and Restated Plan that was presented to the Company's stockholders at the Special Meeting 17,444,4436,228,67213,100 ---- 74%Not verified—

Source: SKYE BIOSCIENCE INC., Form 8-K, filed with the SEC on October 24, 2024 — read the filing on EDGAR.

How asset managers voted at the SKYE BIOSCIENCE INC. 2024-2025 meetings

Each item below shows how the 92 asset managers that disclosed a SKYE BIOSCIENCE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SKYE BIOSCIENCE INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Andrew J. Schwab

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 6, 2025.

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 17,746,927WITHHELD: 2,117,267
Details: description as filed, official tally, votes by 27 asset managers

Description as filed by funds: Election of Directors: Andrew J. Schwab

SKYE BIOSCIENCE INC.’s own tally for this item (“Elect Director: Andrew J. Schwab”): 17,746,927 for, 2,117,267 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the six nominees named in the proxy statement for the 2025 Annual Meeting (the "Proxy Statement") as members of the Board of Directors for a one-year term expiring at the Company's 2026 annual meeting of stockholders.”
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 1,307,453 for, 30,435 withheld.

FOR
FOR: 1,307,453WITHHOLD: 30,435
Largest asset managers voting on “Election of Directors: Andrew J. Schwab” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard891,0740 00For
BlackRock322,0640 00For
Equitable40,2090 00For
Lincoln Financial00 013,700Withhold
Global X12,1440 00For
Fidelity9,0860 00For
Pacific Life7,9400 00For
Bridge Builder Trust6,5050 00For
AIG/SunAmerica00 05,720Withhold
Nationwide5,6130 00For
Northern Trust5,6020 00For
Charles Schwab3,5130 00For
ProShares00 03,448Withhold
DWS00 03,129Withhold
Voya1,8720 00For
Calvert00 01,687Withhold
Goldman Sachs1,1750 00For
State Street00 0988Withhold
Brinker Capital Destinations Trust00 0836Withhold
PENN SERIES FUNDS INC00 0700Withhold
Columbia Threadneedle3850 00For
TIAA2340 00For
Guggenheim00 0158Withhold
BRIDGEWAY FUNDS INC00 048Withhold
QUANTITATIVE MASTER SERIES LLC370 00For

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

2. Elect Director: Annalisa Jenkins

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 6, 2025.

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 19,597,696WITHHELD: 266,498
Details: description as filed, official tally, votes by 27 asset managers

Description as filed by funds: Election of Directors: Annalisa Jenkins

SKYE BIOSCIENCE INC.’s own tally for this item (“Elect Director: Annalisa Jenkins”): 19,597,696 for, 266,498 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the six nominees named in the proxy statement for the 2025 Annual Meeting (the "Proxy Statement") as members of the Board of Directors for a one-year term expiring at the Company's 2026 annual meeting of stockholders.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 1,325,892 for, 11,996 withheld.

FOR
FOR: 1,325,892WITHHOLD: 11,996
Largest asset managers voting on “Election of Directors: Annalisa Jenkins” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard891,0740 00For
BlackRock322,0640 00For
Equitable40,2090 00For
Lincoln Financial13,7000 00For
Global X12,1440 00For
Fidelity00 09,086Withhold
Pacific Life7,9400 00For
Bridge Builder Trust6,5050 00For
AIG/SunAmerica5,7200 00For
Nationwide5,6130 00For
Northern Trust5,6020 00For
Charles Schwab3,5130 00For
ProShares3,4480 00For
DWS3,1290 00For
Voya1,8720 00For
Calvert00 01,687Withhold
Goldman Sachs00 01,175Withhold
State Street9880 00For
Brinker Capital Destinations Trust8360 00For
PENN SERIES FUNDS INC7000 00For
Columbia Threadneedle3850 00For
TIAA2340 00For
Guggenheim1580 00For
BRIDGEWAY FUNDS INC00 048Withhold
QUANTITATIVE MASTER SERIES LLC370 00For

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

3. Elect Director: Deborah Charych

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 6, 2025.

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 18,867,541WITHHELD: 996,653
Details: description as filed, official tally, votes by 27 asset managers

Description as filed by funds: Election of Directors: Deborah Charych

SKYE BIOSCIENCE INC.’s own tally for this item (“Elect Director: Deborah Charych”): 18,867,541 for, 996,653 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the six nominees named in the proxy statement for the 2025 Annual Meeting (the "Proxy Statement") as members of the Board of Directors for a one-year term expiring at the Company's 2026 annual meeting of stockholders.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 945,099 for, 64,183 withheld, 328,606 abstained.

FORABSTAIN
FOR: 945,099ABSTAIN: 328,606WITHHOLD: 64,183
Largest asset managers voting on “Election of Directors: Deborah Charych” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard891,0740 00For
BlackRock00 322,0640Abstain
Equitable9,0600 031,149Mixed
Lincoln Financial13,7000 00For
Global X00 012,144Withhold
Fidelity9,0860 00For
Pacific Life00 07,940Withhold
Bridge Builder Trust00 6,5050Abstain
AIG/SunAmerica5,7200 00For
Nationwide00 05,613Withhold
Northern Trust00 05,602Withhold
Charles Schwab3,5130 00For
ProShares3,4480 00For
DWS3,1290 00For
Voya1,8720 00For
Calvert00 01,687Withhold
Goldman Sachs1,1750 00For
State Street9880 00For
Brinker Capital Destinations Trust8360 00For
PENN SERIES FUNDS INC7000 00For
Columbia Threadneedle3850 00For
TIAA2340 00For
Guggenheim1580 00For
BRIDGEWAY FUNDS INC00 048Withhold
QUANTITATIVE MASTER SERIES LLC00 370Abstain

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

4. Elect Director: Karen Smith

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 6, 2025.

Combines 3 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 18,048,013WITHHELD: 1,816,181
Details: description as filed, official tally, votes by 27 asset managers

Description as filed by funds: Election of Directors: Karen Smith

SKYE BIOSCIENCE INC.’s own tally for this item (“Elect Director: Karen Smith”): 18,048,013 for, 1,816,181 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the six nominees named in the proxy statement for the 2025 Annual Meeting (the "Proxy Statement") as members of the Board of Directors for a one-year term expiring at the Company's 2026 annual meeting of stockholders.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 1,323,292 for, 14,596 withheld.

FOR
FOR: 1,323,292WITHHOLD: 14,596
Largest asset managers voting on “Election of Directors: Karen Smith” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard891,0740 00For
BlackRock322,0640 00For
Equitable40,2090 00For
Lincoln Financial13,7000 00For
Global X12,1440 00For
Fidelity9,0860 00For
Pacific Life7,9400 00For
Bridge Builder Trust6,5050 00For
AIG/SunAmerica00 05,720Withhold
Nationwide5,6130 00For
Northern Trust5,6020 00For
Charles Schwab3,5130 00For
ProShares00 03,448Withhold
DWS00 03,129Withhold
Voya1,8720 00For
Calvert00 01,687Withhold
Goldman Sachs1,1750 00For
State Street9880 00For
Brinker Capital Destinations Trust8360 00For
PENN SERIES FUNDS INC7000 00For
Columbia Threadneedle00 0385Withhold
TIAA2340 00For
Guggenheim00 0158Withhold
BRIDGEWAY FUNDS INC00 048Withhold
QUANTITATIVE MASTER SERIES LLC370 00For

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

5. Elect Director: Paul Grayson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 6, 2025.

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD
FOR: 16,982,420WITHHELD: 2,881,774
Details: description as filed, official tally, votes by 27 asset managers

Description as filed by funds: Election of Directors: Paul Grayson

SKYE BIOSCIENCE INC.’s own tally for this item (“Elect Director: Paul Grayson”): 16,982,420 for, 2,881,774 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the six nominees named in the proxy statement for the 2025 Annual Meeting (the "Proxy Statement") as members of the Board of Directors for a one-year term expiring at the Company's 2026 annual meeting of stockholders.”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 905,970 for, 103,312 withheld, 328,606 abstained.

FORABSTAIN
FOR: 905,970ABSTAIN: 328,606WITHHOLD: 103,312
Largest asset managers voting on “Election of Directors: Paul Grayson” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard891,0740 00For
BlackRock00 322,0640Abstain
Equitable9,0600 031,149Mixed
Lincoln Financial00 013,700Withhold
Global X00 012,144Withhold
Fidelity00 09,086Withhold
Pacific Life00 07,940Withhold
Bridge Builder Trust00 6,5050Abstain
AIG/SunAmerica00 05,720Withhold
Nationwide00 05,613Withhold
Northern Trust5,6020 00For
Charles Schwab00 03,513Withhold
ProShares00 03,448Withhold
DWS00 03,129Withhold
Voya00 01,872Withhold
Calvert00 01,687Withhold
Goldman Sachs00 01,175Withhold
State Street00 0988Withhold
Brinker Capital Destinations Trust00 0836Withhold
PENN SERIES FUNDS INC00 0700Withhold
Columbia Threadneedle00 0385Withhold
TIAA2340 00For
Guggenheim00 0158Withhold
BRIDGEWAY FUNDS INC00 048Withhold
QUANTITATIVE MASTER SERIES LLC00 370Abstain

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

6. Elect Director: Punit Dhillon

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held June 6, 2025.

Combines 3 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 18,059,129WITHHELD: 1,805,065
Details: description as filed, official tally, votes by 27 asset managers

Description as filed by funds: Election of Directors: Punit Dhillon

SKYE BIOSCIENCE INC.’s own tally for this item (“Elect Director: Punit Dhillon”): 18,059,129 for, 1,805,065 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the six nominees named in the proxy statement for the 2025 Annual Meeting (the "Proxy Statement") as members of the Board of Directors for a one-year term expiring at the Company's 2026 annual meeting of stockholders.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 1,323,677 for, 14,211 withheld.

FOR
FOR: 1,323,677WITHHOLD: 14,211
Largest asset managers voting on “Election of Directors: Punit Dhillon” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard891,0740 00For
BlackRock322,0640 00For
Equitable40,2090 00For
Lincoln Financial13,7000 00For
Global X12,1440 00For
Fidelity9,0860 00For
Pacific Life7,9400 00For
Bridge Builder Trust6,5050 00For
AIG/SunAmerica00 05,720Withhold
Nationwide5,6130 00For
Northern Trust5,6020 00For
Charles Schwab3,5130 00For
ProShares00 03,448Withhold
DWS00 03,129Withhold
Voya1,8720 00For
Calvert00 01,687Withhold
Goldman Sachs1,1750 00For
State Street9880 00For
Brinker Capital Destinations Trust8360 00For
PENN SERIES FUNDS INC7000 00For
Columbia Threadneedle3850 00For
TIAA2340 00For
Guggenheim00 0158Withhold
BRIDGEWAY FUNDS INC00 048Withhold
QUANTITATIVE MASTER SERIES LLC370 00For

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

7. To approve the Amended and Restated Omnibus Incentive Plan (the "Amended and Restated Plan"), to, among other things…

Meeting held October 22, 2024.

Combines 3 wordings of this item as funds reported it.

19% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: description as filed, votes by 32 asset managers

Description as filed by funds: To approve the Amended and Restated Omnibus Incentive Plan (the "Amended and Restated Plan"), to, among other things, increase the number of shares available for issuance under the Amended and Restated Plan by 1,535,655 shares.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 30 asset managers voting on “To approve the Amended and Restated Omnibus Incentive Plan (the "Amended and Restated Plan"), to, among other ” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard0677,906 00Against
BlackRock0639,880 00Against
Fidelity0226,204 00Against
AdvisorShares Trust070,000 00Against
Tema ETF Trust56,4320 00For
Charles Schwab051,656 00Against
BRIDGEWAY FUNDS INC050,000 00Against
Equitable040,243 00Against
QUANTITATIVE MASTER SERIES LLC034,337 00Against
TIAA023,389 00Against
Lincoln Financial013,700 00Against
AIG/SunAmerica09,264 00Against
Northern Trust08,004 00Against
Pacific Life07,411 00Against
Bridge Builder Trust07,315 00Against
Brighthouse06,190 00Against
State Street06,173 00Against
Voya05,903 00Against
Nationwide04,422 00Against
John Hancock03,592 00Against
ProShares03,343 00Against
Global X03,048 00Against
DWS02,722 00Against
Calvert01,687 00Against
Victory Capital01,401 00Against

Fund voting reports, all 30 managers: 56,432 for, 1,901,652 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 2 asset managers voting on “To approve the Amended and Restated Omnibus Incentive Plan (the "Amended and Restated Plan"), to, among other ” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Schonfeld Strategic Advisors LLC400,0000 00For
UNITED CAPITAL FINANCIAL ADVISORS, LLC01 00Against

Institutional-manager reports, all 2 managers: 400,000 for, 1 against.

8. The approval, on an advisory basis, of the compensation of the Company's named executive officers, as disclosed in the…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Meeting held June 6, 2025.

Combines 4 wordings of this item as funds reported it.

86% Approved · of votes cast

FOR 86%
FOR: 17,064,084AGAINST: 2,736,116
Details: description as filed, official tally, votes by 86 asset managers

Description as filed by funds: Consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.

SKYE BIOSCIENCE INC.’s own tally for this item (“3. The approval, on an advisory basis, of the compensation of the Company's named executive officers, as disclosed in the Proxy Statement”): 17,064,084 for, 2,736,116 against — passed, per its Form 8-K filed June 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated:”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 27 asset managers voting on “Consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard891,0740 00For
BlackRock0322,064 00Against
Equitable040,209 00Against
Lincoln Financial13,7000 00For
Global X12,1440 00For
Fidelity9,0860 00For
Pacific Life07,940 00Against
Bridge Builder Trust06,505 00Against
AIG/SunAmerica05,720 00Against
Nationwide05,613 00Against
Northern Trust5,6020 00For
Charles Schwab3,5130 00For
ProShares03,448 00Against
DWS03,129 00Against
Voya01,872 00Against
Calvert01,687 00Against
Goldman Sachs01,175 00Against
State Street9880 00For
Brinker Capital Destinations Trust8360 00For
PENN SERIES FUNDS INC7000 00For
Columbia Threadneedle0385 00Against
TIAA2340 00For
Guggenheim0158 00Against
BRIDGEWAY FUNDS INC048 00Against
QUANTITATIVE MASTER SERIES LLC037 00Against

Fund voting reports, all 27 managers: 937,877 for, 400,011 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 71 asset managers voting on “Consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
5AM Venture Management, LLC8,167,2060 00For
Versant Venture Management, LLC2,007,7040 00For
Ensign Peak Advisors, Inc767,2870 00For
DRIEHAUS CAPITAL MANAGEMENT LLC0620,395 00Against
BRAIDWELL LP0578,645 00Against
BlackRock5,347342,985 00Against
State Street314,154645 00For
Global X0297,560 00Against
PLATINUM INVESTMENT MANAGEMENT LTD293,3200 00For
Alyeska Investment Group, L.P.0156,163 00Against
Northern Trust83,2450 00For
MELLON INVESTMENTS Corp037,366 00Against
Two Sigma030,447 00Against
Vanguard10,4185,464 00Mixed
NEW YORK STATE COMMON RETIREMENT FUND13,8000 00For
Rhumbline05,636 00Against
Fidelity010,910 00Against
GEODE CAPITAL MANAGEMENT, LLC9,9360 00For
AllianceBernstein09,060 00Against
JPMorgan08,907 00Against
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM08,130 00Against
Invesco07,310 00Against
T. Rowe Price06,549 00Against
DWS05,508 00Against
Freestone Capital Holdings, LLC05,000 00Against

Institutional-manager reports, all 71 managers: 11,683,480 for, 2,151,640 against, 5,636 1 year. Showing the 25 largest; every one is in the interactive database (link above).

9. Consider and vote upon, on an advisory basis, whether the stockholder vote to approve the compensation of the named…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Meeting held June 6, 2025.

Combines 2 wordings of this item as funds reported it.

15% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 80 asset managers

Description as filed by funds: Consider and vote upon, on an advisory basis, whether the stockholder vote to approve the compensation of the named executive officers as required by Section 14A(a)(2) of the Securities Exchange Act of 1934, as amended, should occur every one, two or three years.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 27 asset managers voting on “Consider and vote upon, on an advisory basis, whether the stockholder vote to approve the compensation of the ” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
BlackRock00 00--
Equitable00 00--
Lincoln Financial00 00--
Global X00 00--
Fidelity00 00--
Pacific Life00 00--
Bridge Builder Trust00 00--
AIG/SunAmerica00 00--
Nationwide00 00--
Northern Trust00 00--
Charles Schwab00 00--
ProShares00 00--
DWS00 00--
Voya00 00--
Calvert00 00--
Goldman Sachs00 00--
State Street00 00--
Brinker Capital Destinations Trust00 00--
PENN SERIES FUNDS INC00 00--
Columbia Threadneedle00 00--
TIAA00 00--
Guggenheim00 00--
BRIDGEWAY FUNDS INC00 00--
QUANTITATIVE MASTER SERIES LLC00 00--

Fund voting reports, all 27 managers: 1,337,888 1 year. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 65 asset managers voting on “Consider and vote upon, on an advisory basis, whether the stockholder vote to approve the compensation of the ” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
5AM Venture Management, LLC00 00--
Ensign Peak Advisors, Inc00 00--
DRIEHAUS CAPITAL MANAGEMENT LLC00 00--
BRAIDWELL LP00 00--
BlackRock00 00--
State Street00 00--
Global X00 00--
PLATINUM INVESTMENT MANAGEMENT LTD00 00--
Alyeska Investment Group, L.P.00 00--
Northern Trust00 00--
MELLON INVESTMENTS Corp00 00--
Two Sigma00 00--
Vanguard00 00--
NEW YORK STATE COMMON RETIREMENT FUND00 00--
Rhumbline05,636 00Against
Fidelity00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
AllianceBernstein00 00--
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM00 00--
Invesco00 00--
T. Rowe Price00 00--
DWS00 00--
Freestone Capital Holdings, LLC00 00--
Charles Schwab00 00--
BANK OF AMERICA NA00 00--

Institutional-manager reports, all 65 managers: 982 for, 5,759 against, 11,049,925 1 year, 767,287 3 year, 8 2 year. Showing the 25 largest; every one is in the interactive database (link above).

10. The ratification of the selection of Marcum as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Meeting held June 6, 2025.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 25,418,814AGAINST: 17,402
Details: description as filed, official tally, votes by 27 asset managers

Description as filed by funds: Consider and vote upon the ratification of the selection of Marcum LLP as our independent registered public accounting firm for the year ending December 31, 2025.

SKYE BIOSCIENCE INC.’s own tally for this item (“2. The ratification of the selection of Marcum as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 25,418,814 for, 17,402 against — passed, per its Form 8-K filed June 11, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The selection was ratified by the votes indicated:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 1,337,888 for.

FOR
FOR: 1,337,888
Largest asset managers voting on “Consider and vote upon the ratification of the selection of Marcum LLP as our independent registered public ac” at SKYE BIOSCIENCE INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard891,0740 00For
BlackRock322,0640 00For
Equitable40,2090 00For
Lincoln Financial13,7000 00For
Global X12,1440 00For
Fidelity9,0860 00For
Pacific Life7,9400 00For
Bridge Builder Trust6,5050 00For
AIG/SunAmerica5,7200 00For
Nationwide5,6130 00For
Northern Trust5,6020 00For
Charles Schwab3,5130 00For
ProShares3,4480 00For
DWS3,1290 00For
Voya1,8720 00For
Calvert1,6870 00For
Goldman Sachs1,1750 00For
State Street9880 00For
Brinker Capital Destinations Trust8360 00For
PENN SERIES FUNDS INC7000 00For
Columbia Threadneedle3850 00For
TIAA2340 00For
Guggenheim1580 00For
BRIDGEWAY FUNDS INC480 00For
QUANTITATIVE MASTER SERIES LLC370 00For

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

Largest SKYE BIOSCIENCE INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 30,984,358 shares outstanding at the time of that meeting.

Fund voting reports: top SKYE BIOSCIENCE INC. shareholders by shares voted on “To approve the Amended and Restated Omnibus Incentive Plan (the "Amended and Restated Plan")…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 2.19%
2BlackRock 2.07%
3Fidelity 0.73%
4AdvisorShares Trust 0.23%
5Tema ETF Trust 0.18%
6Charles Schwab 0.17%
7BRIDGEWAY FUNDS INC 0.16%
8Equitable 0.13%
9QUANTITATIVE MASTER SERIES LLC 0.11%
10TIAA 0.08%
Institutional-manager reports: top SKYE BIOSCIENCE INC. shareholders by shares voted on “Consider and vote upon, on an advisory basis, the compensation of our named executive officers…”, 2024-2025
#Asset manager % of shares outstanding
15AM Venture Management, LLC 26.36%
2Versant Venture Management, LLC 6.48%
3Ensign Peak Advisors, Inc 2.48%
4DRIEHAUS CAPITAL MANAGEMENT LLC 2.00%
5BRAIDWELL LP 1.87%
6BlackRock 1.12%
7State Street 1.02%
8Global X 0.96%
9PLATINUM INVESTMENT MANAGEMENT LTD 0.95%
10Alyeska Investment Group, L.P. 0.50%

Reported SKYE BIOSCIENCE INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

SKYE BIOSCIENCE INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
Entities affiliated with 5AM Ventures VII, L.P. — DEF14A
Andrew J. Schwab — 13D
Entities affiliated with Versant Venture Capital III, L.P. — DEF14A
Sphera Funds Management Ltd. — 13G
BlackRock — 13F
Schonfeld Strategic Advisors LLC — 13G
Vanguard Group — 13F
Geode Capital — 13F
Punit Dhillon, Director, Chief Executive Officer — DEF14A
State Street — 13F

Percentages above are of 30,984,358 shares outstanding, as reported by SKYE BIOSCIENCE INC. on its Form 10-Q dated May 6, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SKYE BIOSCIENCE INC.’s 10-Q dated May 6, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

SKYE BIOSCIENCE INC. proxy season coverage: 2024-2025 (this page).

Cite this page

proxyvotesnow.com, “SKYE BIOSCIENCE (SKYE) 2024-2025 Annual & Special Meetings”, https://proxyvotesnow.com/company/skye-bioscience-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.